Global Dental Implants Market is expected to reach USD 4,497.1 million by 2022 supported by a CAGR of 6.1% during the forecast period of 2017 to 2022. Dental Implant driven by the rising geriatric and edentulous population, increasing incidence of various chronic diseases, growing dental tourism in the emerging markets, increasing disposable incomes in the developing countries, growing integrated dental clinics, and increasing demand of aesthetic & cosmetic dentistry. In addition, growing CAD/CAM industry and rising number of integrated dental clinics provide significant opportunities for the dental implants stakeholders. However, high risk of dental loss linked with dental bridges, high cost of treatment, and difficulty in maintaining oral hygiene hinders the adoption of dental implants to some extent. Moreover, limited reimbursement and pricing pressure faced by the key market players are the major challenges faced by the key players in this market.
Institut Straumann AG
Institut Straumann AG was founded in 1954 and is headquartered at Basel, Switzerland. It is developer and worldwide leader in implants, restorative and regenerative dentistry. In collaboration with the leading clinics, research institutes and universities, the company researches, develops and manufactures dental implants, instruments, prosthetics, and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss.
The geographic presence of the company is in the U.S., Europe, Asia-Pacific, Latin America, and Middle East & Africa.
Camlog Biotechnologies AG was previously known as EBERLE Medizintechnik GmbH, it was formed in 1988. The company used to manufacture dental implants by recognized dentist and dental surgeons in Germany. In 2004, Camlog Biotechnologies AG was formed, and is headquartered at Basel, Switzerland. Camlog Biotechnologies AG operates as a subsidiary of Camlog Holding AG.
Camlog Biotechnologies AG is an established manufacturer and supplier of internationally recognized integrated systems and products for implant dentistry and restorative dentistry.
The company has developed Implant Systems like CAMLOG, and CONELOG. CAMLOG Biotechnologies AG has a strong presence across the globe with its subsidiaries and distribution partners in more than 20 countries in America, Europe, and Asia.
BioHorizons IPH, Inc. was formed in 1994 and is headquartered at Alabama, U.S. It develops evidence-based and scientifically-proven products. It manufactures and sells advanced dental implant technologies and tissue regeneration products for the dental implant industry globally. It offers a spectrum of products for the replacement of missing teeth, including dental implants, restorative and laboratory components, soft and hard tissue biologic products, and surgical planning software. The company offers dental implant systems, biologics, prosthetics, dental instruments and motors, and guided surgery kits.
The company has a strong geographic presence in the North America, Europe, Asia-Pacific, Latin America, Africa, and Australia. BioHorizons IPH, Inc. operates as a subsidiary of Henry Schein, Inc.
Dentsply (Dentsply Sirona)
Dentsply Sirona Inc. was formed in the year 1899 and is headquartered at York, U.S. It is a dental solutions company and manufacturer of professional dental products, technologies, and provides various dental services to the dental industry and patients worldwide. It develops and markets a comprehensive solution offering including dental and oral health products as well as other consumable medical devices.
Dentsply Sirona’s products provide effective solutions to advance patient care and deliver better, safer and faster dentistry. The geographic presence of the company is in North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Zimmer (Zimmer Biomet)
Zimmer Biomet Holdings, Inc. was formed in 1927 and is headquartered at Warsaw, Indiana, U.S. It designs, manufactures, and markets orthopedic reconstructive products, sports medicine, biologics, extremities and trauma products, office based technologies, spine, craniomaxillo facial and thoracic products, dental implants, and related surgical products. It offers dental products that include dental reconstructive implants, dental prosthetic and regenerative products, and bone cement and spinal fusion stimulators.
The geographic presence of the company is in North America, Europe, Asia-Pacific, and Middle East & Africa.
Osstem Implant was formed in 1997 and is headquartered in Seoul, South Korea. It manufactures and supplies dental implants worldwide and provides TS, SS, US, and MS dental implant systems. The company also offers CAS/LAS, ESSET, and 123 Kits to enhance the safety while performing surgeries, bone regeneration materials, units and chairs with panoramic x-rays, impression materials, dental whitening products, and other dental materials and equipment.
The geographic presence of the company is in the North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
HIOSSEN, Inc. was established in Pennsylvania in 2006 as a subsidiary of Osstem Implant. Osstem Implant is leading the Asian-Pacific market with the largest market share and ranked one of the top five dental implant companies in the world. HIOSSEN Inc. produces a wide variety of implants at the state-of-the-art manufacturing facilities in Fairless Hills, PA. Our quality implants are exported to more than 20 different countries in Europe and Asia.
Nobel Biocare is a company that manufactures dental implants and CAD/CAM-based individualized prosthetics and is headquartered in Kloten, Switzerland near the Zürich Airport. Nobel Biocare in its current form was founded in 2002. It originates in a partnership formed in 1978 between Swedish medical researcher Professor Per-Ingvar Brånemark and Bofors, a Swedish company, to industrialize Brånemark’s discovery of osseointegration (the fusing of titanium with bone).